STRS Ohio’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.27M | Buy |
87,800
+83,000
| +1,729% | +$1.19M | 0.01% | 653 |
|
|
2025
Q4 | $68.4K | Buy |
+4,800
| New | +$47.2K | ﹤0.01% | 1904 |
|
|
2025
Q2 | – | Sell |
-3,700
| Closed | -$30.2K | – | 2233 |
|
|
2025
Q1 | $30.2K | Buy |
3,700
+1,800
| +95% | +$16.7K | ﹤0.01% | 1817 |
|
|
2024
Q4 | $17.9K | Sell |
1,900
-8,500
| -82% | -$88.4K | ﹤0.01% | 1819 |
|
|
2024
Q3 | $111K | Buy |
10,400
+1,500
| +17% | +$16.3K | ﹤0.01% | 1689 |
|
|
2024
Q2 | $88.3K | Sell |
8,900
-3,600
| -29% | -$37K | ﹤0.01% | 1720 |
|
|
2024
Q1 | $147K | Sell |
12,500
-4,800
| -28% | -$61.4K | ﹤0.01% | 1622 |
|
|
2023
Q4 | $245K | Sell |
17,300
-53,600
| -76% | -$609K | ﹤0.01% | 1507 |
|
|
2023
Q3 | $862K | Sell |
70,900
-1,100
| -2% | -$14.2K | ﹤0.01% | 953 |
|
|
2023
Q2 | $904K | Sell |
72,000
-19,100
| -21% | -$227K | ﹤0.01% | 967 |
|
|
2023
Q1 | $1.01M | Buy |
91,100
+35,000
| +62% | +$431K | ﹤0.01% | 936 |
|
|
2022
Q4 | $684K | Hold |
56,100
| – | – | ﹤0.01% | 1122 |
|
|
2022
Q3 | $585K | Buy |
56,100
+44,700
| +392% | +$498K | ﹤0.01% | 1255 |
|
|
2022
Q2 | $122K | Buy |
+11,400
| New | +$93.9K | ﹤0.01% | 1721 |
|
|
2021
Q1 | – | Sell |
-84,600
| Closed | -$1.95M | – | 2210 |
|
|
2020
Q4 | $1.95M | Buy |
84,600
+25,100
| +42% | +$513K | 0.01% | 710 |
|
|
2020
Q3 | $840K | Buy |
59,500
+23,500
| +65% | +$343K | ﹤0.01% | 1019 |
|
|
2020
Q2 | $542K | Buy |
36,000
+12,300
| +52% | +$150K | ﹤0.01% | 1248 |
|
|
2020
Q1 | $218K | Buy |
23,700
+13,500
| +132% | +$128K | ﹤0.01% | 1521 |
|
|
2019
Q4 | $99K | Hold |
10,200
| – | – | ﹤0.01% | 1784 |
|
|
2019
Q3 | $81K | Sell |
10,200
-8,700
| -46% | -$94.4K | ﹤0.01% | 1798 |
|
|
2019
Q2 | $235K | Buy |
18,900
+8,100
| +75% | +$103K | ﹤0.01% | 1661 |
|
|
2019
Q1 | $146K | Buy |
10,800
+6,900
| +177% | +$84.3K | ﹤0.01% | 1734 |
|
|
2018
Q4 | $37K | Buy |
3,900
+1,400
| +56% | +$15.4K | ﹤0.01% | 1917 |
|
|
2018
Q3 | $30K | Sell |
2,500
-13,500
| -84% | -$189K | ﹤0.01% | 1999 |
|
|
2018
Q2 | $249K | Buy |
16,000
+3,900
| +32% | +$59K | ﹤0.01% | 1687 |
|
|
2018
Q1 | $181K | Buy |
12,100
+10,100
| +505% | +$154K | ﹤0.01% | 1503 |
|
|
2017
Q4 | $28K | Sell |
2,000
-4,800
| -71% | -$65.9K | ﹤0.01% | 1799 |
|
|
2017
Q3 | $102K | Buy |
+6,800
| New | +$90K | ﹤0.01% | 1642 |
|
|
2015
Q2 | – | Sell |
-28,881
| Closed | -$314K | – | 1882 |
|
|
2015
Q1 | $314K | Buy |
+28,881
| New | +$255K | ﹤0.01% | 1341 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
STRS Ohio's FOLD Position: Q1 2026 in Review
STRS Ohio increased its Amicus Therapeutics (FOLD) stake by 1,729% in Q1 2026, buying an estimated $1.19M and bringing the position to 87,800 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #653.
STRS Ohio first reported a position in FOLD in Q1 2015 and has held it in 29 quarters since. The position peaked at $1.95M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- STRS Ohio held 87,800 shares of Amicus Therapeutics worth $1.27M as of Q1 2026.
- STRS Ohio bought 83,000 Amicus Therapeutics shares in Q1 2026, an estimated $1.19M.
- Amicus Therapeutics made up 0.01% of STRS Ohio's portfolio in Q1 2026, its #653 holding.
- STRS Ohio first reported a position in Amicus Therapeutics in Q1 2015 and has held it in 29 quarters since.
- STRS Ohio's Amicus Therapeutics position peaked at $1.95M in Q4 2020.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.